Oncology Pharma Inc (ONPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 906 | 825 | 1,011 | 872 | 964 |
| Cost of Goods | 300 | 310 | 390 | 300 | 350 |
| Gross Profit | 590 | 530 | 610 | 560 | 610 |
| Operating Expenses | 1,260 | 1,190 | 1,600 | 1,610 | 1,270 |
| Operating Income | -354 | -365 | -589 | -738 | -306 |
| Other Income | 84 | 35 | -1 | -2 | 16 |
| Pre-tax Income | -270 | -330 | -590 | -740 | -290 |
| Net Income Continuous | -279 | -324 | -594 | -741 | -292 |
| Net Income | $-279 | $-324 | $-594 | $-741 | $-292 |
| EPS Basic Total Ops | -15,000,000.00 | -2,000.00 | -3,500.00 | -4,500.00 | -2,000.00 |
| EPS Basic Continuous Ops | -15,000,000.00 | -2,000.00 | -3,500.00 | -4,500.00 | -2,000.00 |
| EPS Diluted Total Ops | -15,000,000.00 | -2,000.00 | -3,500.00 | -4,500.00 | -2,000.00 |
| EPS Diluted Continuous Ops | -15,000,000.00 | -2,000.00 | -3,500.00 | -4,500.00 | -2,000.00 |
| EBITDA(a) | $-254 | $-265 | $-499 | $-658 | $-236 |